April 30, 2008 Encouraging first-quarter 2008 results - Further positive Phase III results for eplivanserin

• Download the press release dated April 30, 2008 (new window, PDF, 0.3 MB)

2006 Research & Development leaflet

"At the heart of health"

• Download 2006 R&D leaflet (new window, PDF, 2.9 MB)

Clip - The life cycle of a drug from research to patients

Find out how a medicine is created

• View the life cycle of a drug video clip

R&D organization

Discovery Research and International Development departments each have their own specific organizational approach but both work towards the same goal: discovering and developing new compounds with the potential to become the groundbreaking drugs of the future and meet major public health needs.

• Project based R&D organization

Research and innovation

Sanofi-aventis research focuses on the development of new approaches, new targets, new pharmaceutical classes and also new formulations.

• Our research strategies

Therapeutic areas

At this time, sanofi-aventis R&D's main objective is to provide patients with effective well-tolerated medicines in our major therapeutic areas.

• Our major therapeutic areas